Direct sequencing of the HA gene of clinical equine H3N8 influenza virus and comparison with laboratory derived viruses.

The research article explores the genetic sequence changes in equine influenza viruses when they are grown in lab conditions using hens’ eggs or mammalian cell culture, and compares these changes to the original virus found in clinical material. The study finds the egg-based propagation suitable for vaccine production and surveillance, but cautions about potential variations when equine influenza vaccines are produced in eggs or mammalian cell cultures.

Objective of the Research

• The main purpose of this research was to investigate the changes in the Hemagglutinin (HA) gene sequence of the equine influenza virus when propagated in different laboratory environments – specifically, hens’ eggs and mammalian cell cultures.
• The goal was to see if these lab-grown viruses differed from the original virus found in clinical materials, in order to better understand possible issues with vaccine development and viral surveillance.

Methods and Procedures

• The research used sequencing of the HA gene to analyse equine influenza viruses grown in both hens’ eggs and mammalian cell cultures, focusing on any alterations in the genetic composition of the virus when compared with the original clinical virus.
• The scientific team then compared these lab-grown viruses to clinically derived human influenza viruses, which are well-known for their ability to grow in MDCK cells without any change.

Findings of the Research

• The research found that while human influenza viruses remained stable in the laboratory environment, equine influenza viruses showed variations when grown in both eggs and mammalian cell cultures. This means that the equine influenza virus didn’t remain exactly the same as when it was clinically derived, unlike its human counterpart.
• The study established that despite these alterations, using eggs for equine influenza virus surveillance and vaccine production is still suitable and effective.

Implications of the Research

• The study emphasizes the need for caution when equine influenza vaccines are produced in eggs or on mammalian cell cultures, due to the potential for genomic variations that could impact vaccine effectiveness.
• The findings underscore the importance of close surveillance and careful quality control in the process of vaccine development and manufacture, to ensure the authenticity and effectiveness of the final product.